COLL vs GEN · P/E 17, rev $181.9M vs P/E 17, rev $5.00B
Collegium Pharmaceutical Inc (COLL) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the COLL and GEN stock pages for the full models.
Not investment advice.